Skip to main content
. 2017 Sep 6;8(53):91481–91493. doi: 10.18632/oncotarget.20690

Figure 1. Rationale for the design of 2-(substituted benzylidene)malononitrile analogs.

Figure 1

R represents a hydroxyl group, a methoxy group, an ethoxy group or a bromo group, and may be substituted with 1 to 3 substituents. In the synthesis of BMN12, 1, 4-dioxane was added to improve the solubility of 3, 5-dibromo-4-hydroxybenzaldehyde, the starting material.